Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma

Cancer

Volumn 82, Issue 4, 1998, Pages 642-650

  Koshiba, Takatomo ^a   Hosotani, Ryo ^a   Wada, Michihiko ^a   Miyamoto, Yoshiharu ^a   Fujimoto, Koji ^a   Lee, Jeon Uk ^a   Doi, Ryuichiro ^a   Arii, Shigeki ^a   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Matrix metalloproteinase 2; Pancreatic carcinoma; Tissue; Western blot analysis; Zymography

Indexed keywords

GELATINASE A;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; IMMUNOBLOTTING; LYMPH NODE METASTASIS; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; COLLAGENASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; FEMALE; GELATINASES; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS;

EID: 0032519608     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980215)82:4<642::AID-CNCR5>3.0.CO;2-N     Document Type: Article

References (28)

1. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284 (5751):67-8.
2. Liotta LA, Stetler SW. Metalloproteinases and cancer invasion. Semin Cancer Biol 1990; 1(2):99-106.
3. Stetler SW, Liotta LA, Kleiner DJ. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. Faseb J 1993; 7(15):1434-41.
4. Poulsom R, Pignatelli M, Stetler SW, Liotta LA, Wright PA, Jeffery RE, et al. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 1992; 141 (2):389-96.
5. Zucker S, Lysik RM, Malik M, Bauer BA, Caamano J, Klein SA. Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis. Int J Cancer 1992; 52(3):366-71.
6. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, et al. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992; 7(1):77-83.
7. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells [see comments]. Nature 1994; 370(6484):61-5.
8. Yamagata S, Yoshii Y, Suh JG, Tanaka R, Shimizu S. Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues. Cancer Lett 1991; 59(1):51-5.
9. Brown PD, Bloxidge RE, Stuart NS, Gatter KC, Carmichael J. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 1993; 85(7):574-8.
10. Gress TM, Muller PF, Lerch MM, Friess H, Buchler M, Adler G. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer 1995; 62(4):407-13.
11. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980; 102(1):196-202.
12. Hermanek P, Sobin LH. UICC TNM classification of malignant tumors. 4th edition. 2nd revision. Berlin: Springer-Verlag, 1992:71-3.
13. Wada M, Doi R, Hosotani R, Lee JU, Fujimoto K, Koshiba T, et al. Expression of Bcl-2 and PCNA in duct cells after pancreatic ligation in rats. Pancreas 1997; 15(2):176-82.
14. Tamakoshi K, Kikkawa F, Nawa A, Maeda O, Kawai M, Sugamuma M, et al. Different pattern of zymography between human gynecologic normal and malignant tissues. Am J Obstet Gynecol 1994; 171(2):478-84.
15. Tamakoshi K, Kikkawa F, Nawa A, Ishikawa H, Mizuno K, Tamakoshi A, et al. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form. Cancer 1995; 76(12):2565-71.
16. Azzam HS, Arand G, Lippman ME, Thompson EW. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 1993; 85(21):1758-64.
17. Fisher C, Gilbertson Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA. Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 1994; 162(2):499-510.
18. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990; 6(4):121-5.
19. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 1993; 221(1-2):91-103.
20. Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin Chim Acta 1993; 220(1):31-45.
21. Nomura H, Sato H, Seiki M, Mai M, Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995; 55(15):3263-6.
22. Okada A, Bellocq JP, Rouger N, Chenard MP, Rio MC, Chambon P, et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 1995; 92(7):2730-4.
23. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995; 270(10):5331-8.
24. Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, et al. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 1996; 56(12):2707-10.
25. Gilles C, Polette M, Piette J, Munaut C, Thompson EW, Birembaut P, et al. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 1996; 65(2):209-13.
26. Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res 1996; 56(12):2815-22.
27. Watson SA, Morris TM, Robinson G, Crimmin MJ, Brown PD, Hardcastle JD. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res 1995; 55(16):3629-33.
28. Chirivi RG, Garofalo A, Crimmin MJ, Bawden LJ, Stoppacciaro A, Brown PD, et al. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 1994; 58(3):460-4.